Cutoff values of D-dimer and FDP in plasma for the diagnosis of thrombosis

Vascular Disease Prevention

Volumn 5, Issue 2, 2008, Pages 81-88

  Kaneko, Toshihiro ^a   Wada, Hideo ^a,b   Onishi, Katsuya ^a   Abe, Yasunori ^a   Ota, Satoshi ^a   Yamada, Norikazu ^a   Matsmoto, Takeshi ^a   Katayama, Naoyuki ^a   Sudou, Akihiro ^a   Uchida, Atsumasa ^a   Nobori, Tsutomu ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

D dimer; Deep vein thrombosis; Fibrin and fibrinogen degradation products; Hypercoagulable state

Indexed keywords

D DIMER; FIBRINOGEN DEGRADATION PRODUCT;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; THROMBOSIS;

EID: 43049087392     PISSN: 15672700     EISSN: None     Source Type: Journal    
DOI: 10.2174/156727008784223954     Document Type: Article

References (32)

1. Linkins LA, Bates SM, Ginsberg JS, et al. Use of different D-dimer levels to exclude venous thromboembolism depending on clinical pretest probability. J Thromb Haemost 2004; 2: 1256-60.
2. Le Gal G, Bounameaux H. Diagnosing pulmonary embolism: running after the decreasing prevalence of cases among suspected patients. J Thromb Haemost 2004; 2: 1244-6.
3. Kline JA, Mitchell AM, Kabrhel C, et al. Clinical criteria to prevent unnecessary diagnostic testing in emergency department patients with suspected pulmonary embolism. J Thromb Haemost 2004; 2: 1247-55.
4. Wada H, Sakuragawa N, Shiku H. Hemostatic molecular markers before onset of disseminated intravascular coagulation in leukemic patients. Semin Thromb Hemost 1998; 24: 293-297.
5. Lehman CM, Wilson LW, Rodgers GM. Analytic validation and clinical evaluation of the STA LIATEST immunoturbidimetric D-dimer assay for the diagnosis of disseminated intravascular coagulation. Am J Clin Pathol 2004; 122: 178-84.
6. Tanigawa M, Wada H, Minamikawa K, et al. Decreased protein C inhibitor after percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction. Am J Hematol 1995; 49: 1-5.
7. Saito Y, Wada H, Yamamuro M, et al. Changes of plasma hemostatic markers during percutaneous transluminal coronary angioplasty in patients with chronic coronary artery disease. Am J Hematol 1999; 61: 238-42.
8. Wada H, Kaneko T, Ohiwa M, et al. Increased levels of vascular endothelial cell markers in thrombotic thrombocytopenic purpura. Am J Hematol 1993; 44: 101-5.
9. Moresco RN, Vargas LC, Silla L. Estimation of the levels of D-dimer by use of an alternative method based in the reaction time of fibrinogen/fibrin degradation products assay. J Thromb Thrombolysis 2007; 24: 73-6.
10. Taylor Jr FB, Toh CH, Hoots WK, et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86: 1327-30.
11. Nieuwenhuizen W. A reference material for harmonization of D-dimer assays. Thromb Haemost 1997; 77: 1031-3.
12. Dempfle CE, Zips S, Ergül H, et al. The fibrin assay comparison trial (FACT). Thromb Haemost 2001; 85: 671-8.
13. Heit JA, Silverstein MD, Mohr DN, et al. The epidemiology of venous thromboembolism in the community. Thromb Haemost 2001; 86: 452-63.
14. Oger E. Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost 2000; 83: 657-60.
15. Courtney DM, Kline JA. Identification of prearrest clinical factors associated with outpatient fatal pulmonary embolism. Acad Emerg Med 2001; 8: 1136-42.
16. Wells PS, Anderson DR, Rodger M, et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med 2003; 349: 1227-35.
17. Fedullo PF, Tapson VF. The evaluation of suspected pulmonary embolism. N Engl J Med 2003; 349: 1247-55.
18. Levi M, de Jonge E, van der Poll T, et al. Disseminated intravascular coagulation. Thromb Haemost 1999; 82: 695-705.
19. Wada H. Disseminated intravascular coagulation. Clin Chim Acta CCA 2004; 344: 13-21.
20. Okabayashi K, Wada H, Ohta S, et al. Hemostatic markers and the sepsis-related organ failure assessment score in patients with disseminated intravascular coagulation in an intensive care unit. Am J Hematol 2004; 76: 225-9.
21. Wada H, Wakita Y, Nakase T, et al. Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Thromb Haemost 1995; 74: 848-52.
22. Goldstein BJ, Mushlin AI. Use of a single thyroxine test to evaluate ambulatory medical patients for suspected hypothyroidism. J Gen Intern Med 1987; 2: 20-4.
23. Wada H, Kobayashi T, Abe Y, et al. Elevated levels of soluble fibrin or D-dimer indicate high risk of thrombosis. J Thromb Haemost 2006; 4: 1253-8.
24. Ota S, Wada H, Nobori T, et al. Diagnosis of deep vein thrombosis by plasma-soluble fibrin or D-dimer. Am J Hematol 2005; 79: 274-80.
25. Minamikawa K, Wada H, Wakita Y, et al. Increased activated protein C-protein C inhibitor complex levels in patients with pulmonary embolism. Thromb Haemost 1994; 71: 192-4.
26. Yamada N, Wada H, Nakase T, et al. Hemostatic abnormalities in patients with pulmonary embolism compared with that in deep vein thrombosis. Blood Coagul Fibrinolysis 1995; 6: 627-33.
27. Wada H, Mori Y, Shimura M, et al. Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries. Am J Hematol 1998; 58: 189-94.
28. Wada H, Mori Y, Kaneko T, et al. Elevated plasma levels of vascular endothelial cell markers in patients with hypercholesterolemia. Am J Hematol 1993; 44: 112-116.
29. Moresco RN, Vargas LC, Voegeli CF, et al. D-dimer and its relationship to fibrinogen/fibrin degradation products (FDPs) in disorders associated with activation of coagulation or fibrinolytic systems. J Clin Lab Anal 2003; 17: 77-9.
30. Takahashi H, Tatewaki W, Wada K, et al. Thrombin vs. plasmin generation in disseminated intravascular coagulation associated with various underlying disorders. Am J Hematol 1990; 33: 90-5.
31. Asakura H, Suga Y, Yoshida T, et al. Pathophysiology of disseminated intravascular coagulation (DIC) progresses at a different rate in tissue factor-induced and lipopolysaccharide-induced DIC models in rats. Blood Coagul Fibrinolysis 2003; 14: 221-8.
32. Kline JA, Wells PS. Methodology for a rapid protocol to rule out pulmonary embolism in the emergency department. Am Emerg Med 2003; 42: 266-75.